The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)

Clinical trial NCT01265498 · COMPLETED

Trial details

NCT number: NCT01265498
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)

Start date: 2011-03-01
Primary completion: 2014-01-01
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.